THE BACTERIA ASSOCIATED SEPSIS IN PATIENTS WITH VALVULAR HEART DISEASE (1/2018 – 6/2022)

Văn Dũng Nguyễn1,, Thị Thanh Huyền Phạm2, Đình Phong Phan2
1 Bach Mai Hospital
2 HMU

Main Article Content

Abstract

Objective: Describle bacteria associated sepsis in patients with ValVular heart disease at National Hospital of Tropical Disease and Bach Mai Hospital. Subjects and methods: Cross-sectional description of 239 inpatients at at National Hospital of Tropical Disease and Bach Mai Hospital from January 2018 to June 2022. Result: The most patient male 64,4% and common in the age group of 30 – 59 years old (50,6%). Farming accounted for the highest proportion (20.5%) followed by pensioners and employees. Most of the people in the study were patients with no history of heart disease, heart ValVes (66.9%) and no prior surgical interVention (86.4%). The most common etiologies were S.aureus, E.coli, S.Viridans group, CoNS (Coagulase negatiVe Staphylococci) group and K.pneumoniae, in which S.aureus accounted for the highest rate of 35.6%. There was no difference in 5 common etiological groups between natural and artificial heart ValVes. Conclusion: The fiVe most common etiological groups are S.aureus, E.coli, S.Viridans, CoNS and K.pneumoniae. MRSA is 62.4% and E.coli with ESBL positiVe. There was no difference in 5 common etiological groups between natural and prosthetic heart ValVes. Conclusion: The most common etiological groups are S.aureus, E.coli, S.Viridans, CoNS and K.pneumoniae. MRSA is 62.4% and E.coli with ESBL positiVe. There was no difference in 5 common etiological groups between natural and artificial heart ValVes.

Article Details

References

1. Hajj J, Blaine N, Salavaci J, Jacoby D. The “Centrality of Sepsis”: A ReView on Incidence, Mortality, and Cost of Care. Healthcare. 2018;6(3). doi:10.3390/healthcare6030090.
2. Sunil M, Hieu HQ, Arjan Singh RS, Ponnampalavanar S, Siew KSW, Loch A. EVolVing trends in infectiVe endocarditis in a deVeloping country: a consequence of medical progress? Annals of Clinical Microbiology and Antimicrobials. 2019;18(1):43. doi:10.1186/s12941-019-0341-x
3. Martín-Dávila P, Fortún J, Navas E, et al. Nosocomial Endocarditis in a Tertiary Hospital: An Increasing Trend in NatiVe ValVe Cases. Chest. 2005;128(2):772-779. doi:10.1378/chest.128.2.772

4. Murdoch DR, Corey GR, Hoen B, et al. Clinical Presentation, Etiology, and Outcome of InfectiVe Endocarditis in the 21st Century: The International Collaboration on Endocarditis– ProspectiVe Cohort Study. ArchiVes of Internal Medicine. 2009;169(5):463-473. doi:10.1001/ archinternmed.2008.603
5. Lomas JM, Martínez-Marcos FJ, Plata A, et al. Healthcare-associated infectiVe endocarditis: an undesirable effect of healthcare uniVersalization. Clinical Microbiology and Infection. 2010;16(11):1683-1690. doi:10.1111/ j.1469-0691.2010.03043.x
6. Phạm Thị Lan và cộng sự. Đặc điểm các trường hợp nhiễm khuẩn huyết liên quan đường truyền tĩnh mạch trung tâm tại bệnh Viện Đại học Y dược Thành phố Hồ Chí Minh. Thời sự Y học 12/2017. http://hoiyhoctphcm.org.Vn/wp- content/uploads/2018/06/07F-BS-Lan- nhi%E1%BB%85m khu%E1%BA%A9n- huy%E1%BA%BFt-CVC-5tr35-39-.pdf
7. van Hal SJ, Lodise TP, Paterson DL. The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in S.aureus Infections: A Systematic ReView and Meta-analysis. Clin Infect Dis. 2012;54(6):755-771. doi:10.1093/cid/cir935